Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Key Background. Zantac, sold generically as ranitidine, was a best-seller and one of the first drugs to achieve blockbuster status by topping $1 billion in annual sales. The drug, used to treat ...

The science that led to Zantac’s withdrawal is very different from the basis of the recently dismissed Zantac litigation (“The Zantac Scare and Junk Science,” Review & Outlook, Dec. 9). The ...

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer.

Zantac exec testifies on claims that heat degraded heartburn drug into cancer-causing substance The plaintiff’s lawyers argue the drug degraded into NDMA when exposed to hot, humid conditions.

Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims The executive, a medical doctor who oversaw drug safety for decades at drugmaker GSK, ...

The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...